The Quantellect read.As of Nov 19, 2026, 12 active firms cover MetLife Inc: 11 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $99.00 to $114.00, so the covering firms are broadly aligned. The average target of $108.17 sits 8% above the current $99.80. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.58 next quarter toward $11.18 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 active firms
Buy
Strong Buy00%
Buy1192%
Neutral18%
Sell00%
Strong Sell00%
Based on 12 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$108.17
+8.4% upside
Average target across 12 active firms as of Nov 19, 2026 vs $99.80 current
Highest Target$114.00
Average Target$108.17
Lowest Target$99.00
Detailed analyst forecasts for MET
Showing 1–16 of 16 named analysts shown · 12 active firms in the rating projection
As of Nov 19, 2026, 11 of 12 active firms rate MET a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
MET EPS & revenue forecast
EPS · NEXT QUARTER
$2.58
Range $2.39 – $2.78 · 11 analysts · +7% YoY
Next period, 11 analysts expect MetLife Inc to earn $2.58 a share (range $2.39 – $2.78), versus $2.42 a year earlier. Full-year consensus is $10.23, growing to $11.18 the year after.
REVENUE · NEXT QUARTER
$20.5B
Range $20.1B – $20.7B · 11 analysts · +4% YoY
Revenue is expected to reach $20.5B (range $20.1B – $20.7B), +3.9% year-over-year. Full-year consensus is $79.5B, rising to $83.0B next year.
Top analysts covering MetLife Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MET.
#1
Alex Scott
Barclays · Rank #38
Buy
$111.00+11.2% to target
Overall win rate
58%
+ Follow
#2
Elyse Greenspan
Wells Fargo · Rank #85
Buy
$101.00+1.2% to target
Overall win rate
57%
+ Follow
#3
Paul Newsome
Piper Sandler · Rank #272
Buy
$110.00+10.2% to target
Overall win rate
50%
+ Follow
#4
WC
Wesley Carmichael
Wells Fargo
Buy
$110.00+10.2% to target
Coverage
—
+ Follow
#5
RK
Ryan Krueger
Keefe, Bruyette & Woods
Buy
$108.00+8.2% to target
Coverage
—
+ Follow
MET stock forecast FAQ
What is MET's average 12-month price target?+
The 12 active firms with a live target average $108.17 for MetLife Inc over the next 12 months, ranging from a $114.00 high to a $99.00 low, as of Nov 19, 2026.
Is MET stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 12 active firms as of Nov 19, 2026, 11 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for MET?+
The Street-high target is $114.00 (TD Cowen), and the Street-low is $99.00 (B of A Securities). The average of all 12 active-firm targets is $108.17.
How many active Wall Street firms cover MET?+
12 active firms have a recognized rating on MetLife Inc as of Nov 19, 2026, and 12 active firms carry a live 12-month price target.
Who is the most accurate analyst covering MET?+
Among analysts who currently cover MET, Alex Scott of Barclays has the strongest overall Quantellect track record (Rank #38). Their current call is Buy with a $111.00 target.
What is MetLife Inc's projected EPS for next quarter?+
The consensus estimate is $2.58 per share (range $2.39 – $2.78) across 11 analysts. Full-year EPS is projected at $10.23, rising to $11.18 the following year.
How much revenue is MetLife Inc expected to report next quarter?+
Consensus revenue is $20.5B (range $20.1B – $20.7B). Full-year revenue is projected at $79.5B, growing to $83.0B next year.
Have analysts been upgrading or downgrading MET lately?+
As of Nov 19, 2026, 11 of 12 active firms rate MET a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MET calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.